Savaria (TSE:SIS – Get Free Report) had its price target lifted by equities researchers at National Bank Financial from C$30.00 to C$30.50 in a report issued on Friday,BayStreet.CA reports. The brokerage currently has an “outperform” rating on the stock. National Bank Financial’s target price would suggest a potential upside of 17.53% from the company’s previous close.
Several other brokerages have also recently weighed in on SIS. Desjardins lifted their price objective on Savaria from C$27.00 to C$32.00 and gave the company a “buy” rating in a report on Friday. Stifel Nicolaus raised their price target on Savaria from C$28.00 to C$29.00 and gave the stock a “buy” rating in a research report on Friday. Scotiabank upped their price objective on shares of Savaria from C$25.00 to C$26.00 in a research report on Monday, November 10th. Finally, TD Securities increased their price objective on shares of Savaria from C$27.00 to C$31.00 and gave the stock a “buy” rating in a research note on Thursday. Seven analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of C$30.93.
Get Our Latest Stock Report on Savaria
Savaria Stock Performance
Savaria (TSE:SIS – Get Free Report) last announced its earnings results on Wednesday, March 4th. The company reported C$0.37 earnings per share (EPS) for the quarter. Savaria had a net margin of 6.90% and a return on equity of 10.24%. The firm had revenue of C$241.78 million for the quarter. Equities research analysts expect that Savaria will post 1.2048518 earnings per share for the current fiscal year.
About Savaria
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Featured Stories
- Five stocks we like better than Savaria
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- Trump’s NEW Executive Order – BIG Changes Coming to Retirement Accounts
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
